Assistance program
Medicare Access and CHIP Reauthorization Act (MACRA) Funding Opportunity: Measure Development for the Quality Payment Program
$24.7 Million committed in FY2018–FY2022
- Agency
- Centers for Medicare and Medicaid Services, Health and Human Services, Department of
- Assistance
- Formula Grants (Cooperative Agreements)
- CFDA number
- 93.986
- What it does
- In accordance with section 1848(s)(6) of the Social Security Act, as added by section 102 of the Medicare Access and Children’s Health Insurance Program Reauthorization Act of 2015, this funding opportunity will be used for developing, improving, updating or expanding quality measures for use in the Quality Payment Program under the Merit-Based Incentive Payment System and/or Advanced Alternative Payment Models. Recognizing the benefits of measure development by external stakeholders with
- Who benefits
- Quality Payment Program provides new opportunities to improve care delivery by supporting and rewarding clinicians as they find new ways to engage patients, families, and caregivers and to improve care coordination and population health management. The quality measures in MIPS and APMs serve as the mechanism of measuring the improved care delivery. With this funding opportunity, CMS is engaging eligible entities to develop the quality measures as a way of enhancing the measure portfolio with additional measures for specialties. An enhanced measure portfolio helps to ensure that a higher percentage of providers can use quality measurement to improve their practice. This results in consumers making more informed decisions regarding their healthcare and overall health care quality improvements. The ultimate beneficiaries from this work are providers, consumers, healthcare stakeholders, and anyone interested in quality as the quality measures developed better reflect the complexity and diversity of our healthcare system and improve the quality of healthcare for everyone.
- Who applies
- Clinical specialty societies, clinical professional organizations, patient advocacy organizations, educational institutions, independent research organizations, health systems, and other entities engaged in quality measure development. For this funding opportunity, the above categories are referenced collectively as entity or entities. The language, engaged in quality measure development, pertains to each of the above referenced entities. Entities must: 1) demonstrate, or partner with an organization with demonstrated, quality measure development expertise 2) be engaged in quality measure conceptualization, development, or evaluation 3) be involved in developing evidence-based clinical practice guidelines Otherwise eligible entities must not be actively receiving federal funding for quality measure development, implementation, maintenance, or public reporting activities for quality measures. However, such an entity may be a sub-recipient on one or multiple applications.
- Authorized by
- Section 1848(s)(6) of the Social Security Act, as added by section 102 of the Medicare Access and Children’s Health Insurance Program Reauthorization Act of 2015.
- Program site
- http://www.cms.gov ↗
Committed by fiscal year
Top recipients
By dollars committed.
How to read these numbers
- Committed through this program
Money committed under this assistance listing (its CFDA program), counted in the year each action happened.
- How it's paid
Most programs pay out one way — a grant, or a direct payment to individuals; the flow bar only appears when a program genuinely mixes types.
- Some recipients aren't itemized
For entitlement programs like Social Security and Medicare, the government reports one aggregate instead of naming tens of millions of people, so the recipient roster isn't part of the public record.
- Awards, counted once
An award count is the number of distinct awards with at least one action that year — each counted once, however many times it was amended.
- The colored bars
Every bar on this page splits by how the money moves:
Direct payments